The Ebola outbreak in the Democratic Republic of Congo (DRC) has exceeded 2,000 confirmed cases, including 754 deaths, according to Congolese health authorities. The World Health Organization (WHO) warns that the outbreak may be significantly larger, potentially two to four times the reported figures. The outbreak, caused by the Bundibugyo strain, has spread across five provinces in the central African country.
There is currently no approved vaccine or treatment for this strain, but a clinical trial for an antiviral drug, obeldesivir, began on Tuesday. Developed by US pharma firm Gilead Sciences, the drug has shown promise in pre-clinical models against filoviruses, the family of viruses that cause hemorrhagic fevers.
FAQs
- **How severe is the current Ebola outbreak in DR Congo?** The outbreak has surpassed 2,000 confirmed cases and 754 deaths. WHO warns the actual number may be much higher. - **Which provinces in DR Congo are affected?** The outbreak has spread to five provinces. - **Is there a vaccine or treatment available for this Ebola strain?** Currently, there is no approved vaccine or treatment for the Bundibugyo strain. - **What measures are being taken to combat the outbreak?** A clinical trial for the antiviral drug obeldesivir has begun. NGOs like Doctors Without Borders are calling for an urgent scaling up of the medical response.
